These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 2787379)
1. Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells. Ward PL; Koeppen H; Hurteau T; Schreiber H J Exp Med; 1989 Jul; 170(1):217-32. PubMed ID: 2787379 [TBL] [Abstract][Full Text] [Related]
2. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells. Chen PW; Kaba DS; Ananthaswamy HN Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses. Roberts LK J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813 [TBL] [Abstract][Full Text] [Related]
4. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype. Lynch DH; Daynes RA; Hodes RJ J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117 [TBL] [Abstract][Full Text] [Related]
5. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors. Fortner GW; Kripke ML J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296 [TBL] [Abstract][Full Text] [Related]
6. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo. Hostetler LW; Romerdahl CA; Kripke ML Cancer Res; 1989 Mar; 49(5):1207-13. PubMed ID: 2465081 [TBL] [Abstract][Full Text] [Related]
7. Immunological characterization of tumor-rejection antigens on ultraviolet-light-induced tumors originating in the CB6F1 mouse. Kitajima T; Iwashiro M; Kuribayashi K; Imamura S Cancer Immunol Immunother; 1994 Jun; 38(6):372-8. PubMed ID: 8205558 [TBL] [Abstract][Full Text] [Related]
8. Immune response to ultraviolet-induced tumors. II. Effector cells in tumor immunity. Streeter PR; Fortner GW Transplantation; 1988 Aug; 46(2):250-5. PubMed ID: 3406977 [TBL] [Abstract][Full Text] [Related]
9. Relationship between expression of tumor-specific transplantation antigens and neoplastic transformation in an ultraviolet radiation-induced murine skin cancer. Ananthaswamy HN Cancer Res; 1986 Dec; 46(12 Pt 1):6322-6. PubMed ID: 3779649 [TBL] [Abstract][Full Text] [Related]
10. Generation of antigenic variants from a nonantigenic murine tumor cell line by transfection with a gene encoding a novel tumor-specific transplantation antigen. Kaba DS; McIntyre BW; Kripke ML; Goodenow RS; Schreiber H; Ananthaswamy HN Cancer Res; 1989 Jan; 49(1):38-43. PubMed ID: 2783244 [TBL] [Abstract][Full Text] [Related]
11. Immunologic parameters of ultraviolet carcinogenesis. Kripke ML; Fisher MS J Natl Cancer Inst; 1976 Jul; 57(1):211-5. PubMed ID: 1003502 [TBL] [Abstract][Full Text] [Related]
12. Studies into the transplantation biology of ultraviolet light-induced tumors. Daynes RA; Spellman CW; Woodward JG; Stewart DA Transplantation; 1977 Apr; 23(4):343-8. PubMed ID: 867480 [TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance. Ward PL; Koeppen HK; Hurteau T; Rowley DA; Schreiber H Cancer Res; 1990 Jul; 50(13):3851-8. PubMed ID: 2112981 [TBL] [Abstract][Full Text] [Related]
14. Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro. Van Waes C; Monach PA; Urban JL; Wortzel RD; Schreiber H Tissue Antigens; 1996 May; 47(5):399-407. PubMed ID: 8795140 [TBL] [Abstract][Full Text] [Related]
15. Anti-idiotypic antibodies against UV-induced tumor-specific CTL clones. Preparation in syngeneic combination. Kuribayashi K; Tanaka C; Matsubayashi Y; Masuda T; Udono H; Abe M; Nakayama E; Shiku H J Immunol; 1988 Dec; 141(11):4074-80. PubMed ID: 2460558 [TBL] [Abstract][Full Text] [Related]
16. Enhanced tumorigenicity of cloned UV-regressor tumor lines following selected in vivo and in vitro manipulations. Schmitt MK; Roberts LK; Gahring LC; Daynes RA Am J Pathol; 1983 Dec; 113(3):269-78. PubMed ID: 6650658 [TBL] [Abstract][Full Text] [Related]
17. Ultraviolet light induces tumors with both unique and host-associated antigenic specificities. DeWitt CW J Immunol; 1981 Jul; 127(1):329-34. PubMed ID: 6165770 [TBL] [Abstract][Full Text] [Related]
18. A novel MHC class I molecule as a tumour-specific antigen. Correlation between the antibody-defined and the CTL-defined target structure. Philipps C; Stauss HJ; Wortzel RD; Schreiber H J Immunogenet; 1986; 13(2-3):93-9. PubMed ID: 3493299 [TBL] [Abstract][Full Text] [Related]
19. Immune response to ultraviolet-induced tumors. I. Transplantation immunity developing in syngeneic mice in response to progressor ultraviolet-induced tumors. Fortner GW; Lill PH Transplantation; 1985 Jan; 39(1):44-9. PubMed ID: 2578236 [TBL] [Abstract][Full Text] [Related]